Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02951871
What this trial is testing

Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis

Who this might be right for
This Study Describes the Different Causes of Death in 237 FL Patients
Hospices Civils de Lyon 237
Not applicableActive Not RecruitingNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT05205902
What this trial is testing

TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides

Who this might be right for
Mycosis FungoidesCutaneous T Cell Lymphoma
Assistance Publique - Hôpitaux de Paris 78
Large-scale testing (Phase 3)UnknownNCT03151044
What this trial is testing

R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
FENG Ji-feng 408
Testing effectiveness (Phase 2)Study completedNCT00082303
What this trial is testing

Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma, Non-Hodgkin
National Center for Complementary and Integrative Health (NCCIH) 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Early research (Phase 1)Study completedNCT03472573
What this trial is testing

Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Large-scale testing (Phase 3)Ended earlyNCT02811783
What this trial is testing

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Who this might be right for
Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome
Elorac, Inc. 59
Testing effectiveness (Phase 2)UnknownNCT03617666
What this trial is testing

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Who this might be right for
Hodgkin Lymphoma
University College, London 49
Early research (Phase 1)Study completedNCT00968656
What this trial is testing

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1

Who this might be right for
Breast CancerHead and Neck CancerDiffuse Large B-cell Lymphoma
Washington University School of Medicine 31
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04765111
What this trial is testing

Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 53
Early research (Phase 1)Study completedNCT00047164
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy

Who this might be right for
Lymphoma
National Institutes of Health Clinical Center (CC) 89
Early research (Phase 1)Active Not RecruitingNCT03283137
What this trial is testing

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

Who this might be right for
CLLB-cell Non Hodgkin Lymphoma
University of Chicago 20
Testing effectiveness (Phase 2)UnknownNCT01412307
What this trial is testing

Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Adult Hodgkin Lymphoma
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale 36
Not applicableStudy completedNCT02139592
What this trial is testing

Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"

Who this might be right for
Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
Takeda 292
Large-scale testing (Phase 3)Study completedNCT00012051
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416451
What this trial is testing

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT04083495
What this trial is testing

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Next Page